Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids
NCT ID: NCT06154694
Last Updated: 2025-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
52 participants
OBSERVATIONAL
2021-11-03
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Total shoulder arthroplasty (TSA) has been shown to relieve the pain and improve joint function of patients with OA. However, several complications such as component loosening and polyethylene damage has been reported and it has been revealed that 7.3% of glenoids may show signs of asymptomatic radiographic loosening annually after primary anatomic TSA. The mechanism of such fixation failure is still unclear.
The main goal of this study is evaluating in-vivo glenohumeral contact patterns in patients with osteoarthritic glenoids before and after TSA, to unravel the high rate of glenoid component loosening.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag)
NCT06877936
Focus on the Humeral Component Following Reverse Shoulder Arthroplasty
NCT04809077
Glenohumeral Re-centering During Closed Kinetic Chain for Shoulder Physiotherapy. A Prospective and Randomized Study.
NCT02874105
Glenoid Bone Grafting for RTSA: Clinical & Radiographic Outcomes
NCT03151109
Range-of-motion Analysis of Reverse Shoulder Arthroplasty
NCT04633083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Total shoulder arthroplasty (TSA) has been shown to relieve the pain and improve joint function of patients with OA. However, several complications such as component loosening and polyethylene damage has been reported and it has been revealed that 7.3% of glenoids may show signs of asymptomatic radiographic loosening annually after primary anatomic TSA. Although, aberrant glenohumeral contact mechanics has been suggested to be one of the primary potential causes, the mechanism of such fixation failure is still unclear. Glenohumeral conformity, eccentric loads associated with shoulder instability, bone quality, cementing techniques, implant orientation and design are all confounding factors that indeed affect the mechanical environment of the glenoid component, and, more specifically, also in terms of the contact mechanics.
Knowledge of in vivo glenohumeral joint contact mechanics before and after total shoulder arthroplasty and its interplay with patient- and surgery-related parameters may unravel the high rate of glenoid component loosening in patients with osteoarthritic glenoids and provide insight for the improvement of patient function, implant designs, implant longevity, and surgical technique. Previous ex-vivo and computational modelling studies that focused on the glenohumeral contact area after TSA, suggested that arm elevation in the scapular plane results in aberrant posterior translation of the humeral head in TSA patients. However, an in-vivo study based on dual-plane fluoroscopy, demonstrated that this only occurs in 50% of TSA patients. These discrepancies could arise from analyzing an assorted population of TSA patients without taking into account any specific information with regards to their preoperative osseous and soft-tissue status such as type of glenoid erosion, degree of glenoid retroversion, and amount of rotator cuff degeneration. Postoperative factors such as degree of retroversion correction, amount of joint-line medialization and glenohumeral components' radial mismatch were also not considered in these studies.
The main goal of this study is evaluating in-vivo glenohumeral contact patterns in patients with osteoarthritic glenoids before and after TSA, to unravel the high rate of glenoid component loosening. To that aim, the project is divided into four sub-objectives. The first objective is to compare glenohumeral contact areas before and after surgery in patients with osteoarthritic glenoids, using EOS (micro-dose x-ray) stereo radiographic imaging, to evaluate whether osseous correction during surgery is able to correct glenohumeral joint kinematics. The second objective is to compare OA patient's glenohumeral contact areas before and after surgery with healthy subjects. The third objective is to identifying variations in glenohumeral contact patterns after surgery with respect to the pre-and postoperative state of the patients. The last objective is to evaluate the influence of the location of the glenohumeral contact area after surgery on the long-term outcome and survival of the glenoid component.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shoulder osteoarthritis patients
Patients with glenohumeral osteoarthritis
Stereo Radiographic EOS Measurements
Healthy control will undergo a stereo radiographic EOS exam with their arm in various positions.
1. Relaxed standing (0 degree of abduction)
2. 45 degree of abduction in the coronal plane
3. 90 degree of abduction in the coronal plane
4. 120 degree of abduction in the coronal plane
5. 45 degree anterior flexion in the sagittal plane
6. 90 degree anterior flexion in the sagittal plane
7. 120 degree of anterior flexion in the sagittal plane
8. 45 degree extension in the sagittal plane
Healthy control
Healthy adult volunteers with no history of shoulder pain or trauma
Stereo Radiographic EOS Measurements
Healthy control will undergo a stereo radiographic EOS exam with their arm in various positions.
1. Relaxed standing (0 degree of abduction)
2. 45 degree of abduction in the coronal plane
3. 90 degree of abduction in the coronal plane
4. 120 degree of abduction in the coronal plane
5. 45 degree anterior flexion in the sagittal plane
6. 90 degree anterior flexion in the sagittal plane
7. 120 degree of anterior flexion in the sagittal plane
8. 45 degree extension in the sagittal plane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stereo Radiographic EOS Measurements
Healthy control will undergo a stereo radiographic EOS exam with their arm in various positions.
1. Relaxed standing (0 degree of abduction)
2. 45 degree of abduction in the coronal plane
3. 90 degree of abduction in the coronal plane
4. 120 degree of abduction in the coronal plane
5. 45 degree anterior flexion in the sagittal plane
6. 90 degree anterior flexion in the sagittal plane
7. 120 degree of anterior flexion in the sagittal plane
8. 45 degree extension in the sagittal plane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with glenohumeral osteoarthritis planned for anatomic shoulder arthroplasty in the University Hospitals Leuven, Belgium
* Complete patient informed consent
* Pain free at the time of EOS imaging
Healthy control group
* Healthy adult volunteers with no history of shoulder pain or trauma
* Confirmation of the physician, that subject's clinical evaluation and CT scan did not show any abnormalities
* Complete informed consent
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Filip Verhaegen
Role: PRINCIPAL_INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S64986
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.